Public Health Efforts Can Impact Adoption of Current Susceptibility Breakpoints, but Closer Attention from Regulatory Bodies Is Needed.


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
03 2019
Historique:
received: 13 09 2018
accepted: 11 12 2018
pubmed: 21 12 2018
medline: 29 5 2020
entrez: 21 12 2018
Statut: epublish

Résumé

Microbiological testing, including interpretation of antimicrobial susceptibility testing results using current breakpoints, is crucial for clinical care and infection control. Continued use of obsolete

Identifiants

pubmed: 30567751
pii: JCM.01488-18
doi: 10.1128/JCM.01488-18
pmc: PMC6425187
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Carbapenems 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Clin Infect Dis. 2013 Nov;57(9):1246-52
pubmed: 23946222
Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14
pubmed: 23221186
MMWR Morb Mortal Wkly Rep. 2013 Mar 8;62(9):165-70
pubmed: 23466435
Clin Infect Dis. 2018 Mar 19;66(7):1061-1067
pubmed: 29099915
Antimicrob Agents Chemother. 2012 Sep;56(9):4885-90
pubmed: 22777044
J Clin Microbiol. 2015 Jan;53(1):201-5
pubmed: 25378572
Clin Infect Dis. 2018 Jan 6;66(2):163-171
pubmed: 29020404
Crit Care Nurse. 2017 Dec;37(6):72-80
pubmed: 29196589
J Clin Microbiol. 2016 Nov;54(11):2757-2762
pubmed: 27582516
Chest. 1999 Feb;115(2):462-74
pubmed: 10027448
Open Forum Infect Dis. 2019 Apr 23;6(6):ofz194
pubmed: 31198817
Antimicrob Agents Chemother. 2005 Feb;49(2):760-6
pubmed: 15673761
Infect Control Hosp Epidemiol. 2013 Feb;34(2):144-50
pubmed: 23295560
Emerg Infect Dis. 2014 Jul;20(7):1170-5
pubmed: 24959688
Diagn Microbiol Infect Dis. 2009 Dec;65(4):414-26
pubmed: 19833471

Auteurs

James A McKinnell (JA)

Acute Communicable Disease Control Unit, Los Angeles County Department of Public Health, Los Angeles, California, USA dr.mckinnell@gmail.com.
Infectious Disease Clinical Outcomes Research Unit, Division of Infectious Disease, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California, USA.
David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.

S Bhaurla (S)

Acute Communicable Disease Control Unit, Los Angeles County Department of Public Health, Los Angeles, California, USA.

P Marquez-Sung (P)

Acute Communicable Disease Control Unit, Los Angeles County Department of Public Health, Los Angeles, California, USA.

A Pucci (A)

Acute Communicable Disease Control Unit, Los Angeles County Department of Public Health, Los Angeles, California, USA.

M Baron (M)

Acute Communicable Disease Control Unit, Los Angeles County Department of Public Health, Los Angeles, California, USA.

T Kamali (T)

Acute Communicable Disease Control Unit, Los Angeles County Department of Public Health, Los Angeles, California, USA.

J Bugante (J)

Acute Communicable Disease Control Unit, Los Angeles County Department of Public Health, Los Angeles, California, USA.

B Schwartz (B)

Acute Communicable Disease Control Unit, Los Angeles County Department of Public Health, Los Angeles, California, USA.

S Balter (S)

Acute Communicable Disease Control Unit, Los Angeles County Department of Public Health, Los Angeles, California, USA.

D Terashita (D)

Acute Communicable Disease Control Unit, Los Angeles County Department of Public Health, Los Angeles, California, USA.

S Butler-Wu (S)

University of Southern California, Los Angeles, California, USA.

J Gunzenhauser (J)

Acute Communicable Disease Control Unit, Los Angeles County Department of Public Health, Los Angeles, California, USA.

J Hindler (J)

Acute Communicable Disease Control Unit, Los Angeles County Department of Public Health, Los Angeles, California, USA.

R M Humphries (RM)

David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH